Use of a Polymer Additive To Enhance Impurity Rejection in the Crystallization of a Pharmaceutical Compound
- 14 September 2017
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 21 (10) , 1493-1500
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
This publication has 19 references indexed in Scilit:
- Crystallization of Organic Compounds2008
- Identification of Critical Process Impurities and Their Impact on Process Research and DevelopmentOrganic Process Research & Development, 2008
- Assuring quality of drugs by monitoring impurities☆Advanced Drug Delivery Reviews, 2007
- Increasing the Aqueous Solubility of Acetaminophen in the Presence of Polyvinylpyrrolidone and Investigation of the Mechanisms InvolvedDrug Development and Industrial Pharmacy, 2003
- Pharmaceutical impurities—A mini-reviewAAPS PharmSciTech, 2002
- Crystallization of hydrocortisone acetate: influence of polymersInternational Journal of Pharmaceutics, 2001
- Crystallisation conditions and physicomechanical properties of ibuprofen–Eudragit® S100 spherical crystal agglomerates prepared by the solvent-change techniqueInternational Journal of Pharmaceutics, 1998
- Studies on paracetamol crystals produced by growth in aqueous solutionsInternational Journal of Pharmaceutics, 1994
- Enhanced dissolution and absorption of trimethoprim from coprecipitates with polyethylene glycols and polyvinylpyrrolidoneDrug Development and Industrial Pharmacy, 1991
- Effect of Macromolecules on Aqueous Solubility of Cholesterol and Hormone DrugsJournal of Pharmaceutical Sciences, 1981